Orum Therapeutics, Inc. (KOSDAQ:475830)
114,700
-7,100 (-5.83%)
Jan 19, 2026, 3:30 PM KST
446.19% (1Y)
| Market Cap | 2.44T |
| Revenue (ttm) | 25.48M |
| Net Income (ttm) | -36.88B |
| Shares Out | 21.23M |
| EPS (ttm) | -2,048.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 402,033 |
| Average Volume | 464,746 |
| Open | 120,900 |
| Previous Close | 121,800 |
| Day's Range | 114,100 - 122,500 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 53.89 |
| Earnings Date | Mar 20, 2026 |